- In April 2024, Clario, a leading clinical trial solutions provider, announced the acquisition of ArtiQ, an AI-powered PFT interpretation company. This strategic move aims to enhance Clario's Respiratory Solutions portfolio by integrating advanced AI capabilities, underscoring the growing trend of leveraging artificial intelligence for more accurate and efficient PFT analysis. This development highlights the industry's commitment to improving diagnostic capabilities in respiratory care
- In September 2023, PulmOne, a developer of portable pulmonary function testing devices, launched the MiniBox+ in China. The device was showcased to pulmonologists at the 2023 Annual Congress of the Chinese Thoracic Society (CTS) through its distributor HTDK. This introduction signifies the increasing focus on portable and accessible PFT solutions, particularly in rapidly growing markets such as China, to meet the rising demand for convenient lung function monitoring
- In May 2023, Vitalograph, a prominent leader in respiratory diagnostics, expanded its product portfolio with the introduction of the Vitalograph tremoflo C-100 Oscillometer at the ATS International Conference. This new device emphasizes the shift towards advanced, non-invasive testing methods such as oscillometry, which provides specific information about small airway function without requiring forced maneuvers, making it ideal for a wider range of patients, including children
